OXCARBAZEPINE | A077747 | RUBICON RESEARCH LTD
Highest NADAC/Unit
$0.3180
per ea
Lowest NADAC/Unit
$0.1067
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72888008901OXCARBAZEPINE 600 MG TABLET | $0.3180 | EA | Generic | — | 2026-10-21 |
| 72888008905OXCARBAZEPINE 600 MG TABLET | $0.3180 | EA | Generic | — | 2026-10-21 |
| 72888008801OXCARBAZEPINE 300 MG TABLET | $0.1714 | EA | Generic | — | 2026-10-21 |
| 72888008805OXCARBAZEPINE 300 MG TABLET | $0.1714 | EA | Generic | — | 2026-10-21 |
| 72888008701OXCARBAZEPINE 150 MG TABLET | $0.1067 | EA | Generic | — | 2026-10-21 |
| 72888008705OXCARBAZEPINE 150 MG TABLET | $0.1067 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.